EC Number   |
General Information |
Reference |
|---|
    1.3.1.9 | malfunction |
physiological function of the enzyme is examined by knocking out the gene and determining the effect of the gene disruptions on cell growth and triclosan sensitivity, the gene is not essential |
390505 |
| 1.3.1.9 | metabolism |
enoyl-ACP reductases catalyze the final step in the elongation cycle of the bacterial fatty acid biosynthesis, FAS-II, pathway, but FabV is distinct and belongs to another class of enoyl-acyl carrier protein reductases, overview |
-, 711222 |
| 1.3.1.9 | metabolism |
FabI2 possesses a YX7K type catalytic domain |
763733 |
| 1.3.1.9 | metabolism |
key enzyme in the biosynthesis of mycolic acids |
-, 747498 |
| 1.3.1.9 | metabolism |
main enzyme for type II fatty acid synthesis |
-, 765313 |
| 1.3.1.9 | metabolism |
the enzyme catalyzes the last step in each elongation cycle of type II bacterial fatty acid synthesis and is a key regulatory protein in bacterial fatty acid synthesis |
740527 |
| 1.3.1.9 | metabolism |
the enzyme catalyzes the NADH-dependent reduction of long-chain trans-2-enoyl-ACP fatty acids, an intermediate in mycolic acid biosynthesis |
-, 747286 |
| 1.3.1.9 | metabolism |
the enzyme is a member of the mycobacterial type II dissociated fatty acid biosynthesis system |
-, 747703 |
| 1.3.1.9 | metabolism |
the enzyme is an essential enzyme of the mycolic acid biosynthetic pathway |
-, 748680 |
| 1.3.1.9 | metabolism |
the enzyme is involved in mycolic acid biosynthesis. It is part of the dissociative type 2 fatty acid synthase (FASII) system |
748516 |
